CAPN15: A Protein Interaction with Calpain and Potential Drug Target for Neurodegenerative Diseases

Target Name: CAPN15

NCBI ID: G6650

CAPN15

CAPN15: A Protein Interaction with Calpain and Potential Drug Target for Neurodegenerative Diseases

CAPN15, also known as Calpain-15, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the capnase family, which is a group of proteins that are involved in the regulation of cellular processes such as cell death, inflammation, and signaling.

One of the unique features of CAPN15 is its ability to interact with other proteins, including Calpain, a protein that is involved in the regulation of cell death and is known for its ability to induce cell death in response to various stimuli, such as exercise or starvation. By interacting with Calpain, CAPN15 is able to regulate the level of cell death that occurs in response to these stimuli, which may have important implications for the health and disease associated with Calpain.

In addition to its ability to interact with Calpain, CAPN15 has also been shown to play a role in the regulation of cellular processes that are important for the development and maintenance of tissues. For example, studies have shown that CAPN15 is involved in the regulation of cell proliferation, migration, and the formation of tissues such as blood vessels.

Given the unique combination of features that CAPN15 possesses, it is a promising drug target for the development of new treatments for a variety of conditions. For example, the ability of CAPN15 to interact with Calpain and the regulation of cellular processes that are important for tissue development and maintenance make it a potential target for the treatment of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and other forms of cancer.

In addition to its potential as a drug target, CAPN15 may also be a biomarker for certain diseases. The regulation of cell death and the formation of tissues that are important for the development and maintenance of tissues are involved in the development and progression of many diseases, including neurodegenerative diseases. By targeting CAPN15, researchers may be able to develop new diagnostic tools and therapeutic treatments for these diseases.

Overall, the unique combination of features that CAPN15 possesses makes it a promising drug target and a potential biomarker for the development and treatment of a variety of diseases. Further research is needed to fully understand the role of CAPN15 in these processes and to develop new treatments based on its properties.

Protein Name: Calpain 15

The "CAPN15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CAPN15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets